WCLC 2020 Faculty Chairs Disclosure Summary Name of Individual Individual's Name of Commercial Interest(s) Nature of Relationship(s) Adusumilli, Prasad FacultyRole(s) in Activity 1) ATARA Biotherapeutics (Patents, royalties and intellectual 1) Royalty/Intellectual property/Patent property on mesothelin-targeted CAR and other T-cell holder therapies) 2) Contracted/Support research grant 2) ATARA Biotherapeutics 3) Consultant 3) ATARA Biotherapeutics Aerts, Joachim Chair 1) MSD, BMS, Roche, Astra-Zeneca, BAyer, Eli-Lilly, Boehringer 1) Advisory Board Ingelheim, Takeda, Amphera, BIOCAD 2) Ownership or Stock interest 2) Amphera 3) Royalty/Intellectual property/Patent 3) allogenic tumor cell lysate/JAK inhibition in holder immunooncology/ biomarker for immuno-oncology (all institution) Aggarwal, Charu Faculty 1) BMS, ROCHE, AZ, MERCK, Celgene, BluePrint, Diachaii Sankyo 1) Advisory Board 2)Allogenic tumor cell lysate/JAK inhibition in immuno- 2) Royalties/Intellectual Property/Patent oncology/biomarker for immuno-oncology (all institution) Holder to institution 3) AZ, Merck, Xencor, Novartis 3) Research grants to institution Agrawal, Abhinav Faculty Nothing to disclose Nothing to disclose Ahn, Myung-Ju Faculty 1) AstraZeneca, MSD, Lilly, Bristol-Myers Squibb, Takeda, 1) Advisory Board Amgen, Roche, Merck, Pfizer 2) Consultant 2) Alpha Pharmaceutical, Yuhan, Progenere Aisner, Dara Faculty Nothing to disclose Akerley, Wallace Faculty Nothing to disclose Nothing to disclose Akhtar-Danesh, Gilly Faculty Nothing to disclose Nothing to disclose Ambrogio, Chiara Faculty 1) Revolution Medicines 1) Contracted/Support reseach grant Andarini, Sita Chair 1) Astra Zeneca, Boehringer Ingelheim, MSD, Kalbe Innolab, 1) Speakers Bureau Pfizer, Roche, Takeda 2) Advisory Board 2) Astra Zeneca, Boehringer Ingelheim, MSD, Roche 3) Contracted/Support research grant 3) Astra Zeneca, Boehringer Ingelheim Antonoff, Mara Faculty Nothing to disclose Nothing to disclose Arenberg, Douglas Faculty Nothing to disclose Nothing to disclose Arrato, Nicole Faculty Nothing to disclose Nothing to disclose Arriola Aperribay, Edurne Faculty 1) Roche, Merck, BMS, AstraZeneca, Lilly, Pfizer, Boehringer, 1) Speakers Bureau Takeda 2) Speakers Bureau 2) Travel/ Accomodation: Roche, Merck, BMS, AstraZeneca, Lilly, Pfizer, Boehringer Asamura, Hisao Faculty 1) Johnson and Johnson, Covidien, Taiho, Astelllas, Lily 1) Contracted/Support research grant 2) Foudation Medicine, Roche 2)Consultant 3) Eisai 3) Advisory Board Awad, Mark Faculty 1) Merck, Achilles, Abbvie, AstraZeneca, Bristol-Myers Squibb 1) Consultant 2) AstraZeneca, Genentech, Bristol-Myers Squibb, Eli Lilly and 2) Contracted/Support research grant Company Azar, Ibrahim Faculty Nothing to disclose Nothing to disclose Bai, Xue Faculty Nothing to disclose Nothing to disclose Bakitas, Marie Faculty Nothing to disclose Nothing to disclose Balata, Haval Faculty Nothing to disclose Nothing to disclose Baldwin, David Faculty 1) Honoraria from AZ, MSD, Bristol Myers Squibb and Roche for 1) AdvisoryBoard lectures / webinars / advisory groups Bastani, Mehrad Faculty Nothing to disclose Nothing to disclose Beattie, Vanessa Chair Nothing to disclose Nothing to disclose Belderbos , Robert Faculty Nothing to disclose Nothing to disclose 1/21 WCLC 2020 Faculty Chairs Disclosure Summary Name of Individual Individual's Name of Commercial Interest(s) Nature of Relationship(s) Besse, Benjamin FacultyRole(s) in Activity 1) Abbvie, Amgen, AstraZeneca, Biogen, Blueprint Medicines, 1) Contracted/Support research grant BMS, Celgene, Eli Lilly, GSK, Ignyta, IPSEN, Merck KGaA, MSD, Nektar, Onxeo, Pfizer, Pharma Mar, Sanofi, Spectrum Pharmaceuticals, Takeda, Tiziana Pharma. Investigator or co- investigator of trials: Nerviano, GSK, Pfizer, Roche-Genentech, Lilly, OSE Pharma, MSD, Celgene, Stemcentrx, Ignyta, Abbvie, Loxo Oncology, AstraZeneca, Blueprint Medicines. Best, Sarah Faculty Nothing to disclose Nothing to disclose Bezjak, Andrea Faculty 1) Astra Zeneca 1) Speakers Bureau Bi, Nan Faculty Nothing to disclose Nothing to disclose Blackhall, Fiona Chair 1) Astra Zeneca, Takeda 1) Speakers Bureau 2) AZ Cellgene Roche Amgen 2) Consultant 3) AZ Roche Amgen 3) Contracted/Support research grant Boni, Valentina Faculty Nothing to disclose Nothing to disclose Borghaei, Hossein Chair 1) Genentech, Celgene, Pfizer, Merck, Astra Zeneca, Novartis, 1) Advisory Board Genmab, Regeneron, BioNTech, Cantargia AB, Amgen, Axiom, 2) Ownership or Stock Interest SonnetBio (scientific advisory Board), RGenix (Scientific 3) Honorarium received from promotional Advisory Board) activities 2) SonnetBio, Rgenix 4) Contracted/Support Research Grant 3) Lilly, Pfizer, Daiichi 4) BMS/Lilly, Merck/Celgene, Millennium Borondy-Kitts, Andrea Faculty 1) Johnson & Johnson, Abbvie, Abbott Labs, 1) Ownership or Stock interest 2) Astra Zeneca, Prosumer Health - - a start-up company 2) Other developing an AI driven individualized mobile health platform to help individuals manage their health and healthcare Bosch-Barrera, Joaquim Faculty Nothing to disclose Nothing to disclose Boyer, Michael Faculty 1) Bristol-Myers Squibb, Astra Zeneca, and Janssen 1) Advisory Borad 2) Merck Sharpe and Dohme, Bristol-Myers Squibb, Astra 2) Contracted/Support research grant Zeneca, Amgen, Roche, Pfizer, and Janssen 3) Consultant 3) Cancer Aid Brahmer, Julie Faculty 1) Amgen, AstraZeneca, Bristol Myers Squibb, Genentech, 1) Advisory Board Merck, GlaxoSmithKline, Sanofi 2) Consultant 2) Amgen, AstraZeneca, Bristol Myers Squibb, Genentech, 3) Honorarium received from promotional Merck, GlaxoSmithKline, Sanofi activities 3) Genentech 4) Contracted/Support research grant 4) Bristol Myers Squibb 5) Other - Travel Accomodation Expenses & 5) Travel / Accommodation Expenses: Genentech Data & Safety Safety Monitoring Board/Committees Monitoring Board/Committees: GlaxoSmithKline, Sanofi Brastianos, Priscilla Faculty 1) Angiochem, Merck, Genentech-Roche, Lilly, Tesaro, 1) Consultant ElevateBio,Pfizer (Array), Dantari 2) Contracted/Support research grant 2) Merck, BMS, Lilly 3) Honorarium received from promotional 3) Merck, Genentech-Roche, Lilly, Pfizer activities 2/21 WCLC 2020 Faculty Chairs Disclosure Summary Name of Individual Individual's Name of Commercial Interest(s) Nature of Relationship(s) Bubendorf, Lukas FacultyRole(s) in Activity 1) Boehringer Ingelheim, Astra Zeneca , Eli Lilly, Bayer 1) Advisory Board 2) Roche, Novartis 2) Ownership or Stock interest 3) Bayer 3) Honorarium received from promotional 4) Roche activities 4) Contracted/ Support research grant Burgess, Lisa Faculty Nothing to disclose Nothing to disclose Califano, Raffaele Faculty 1) MSD 1) Institutional Grant Support Calles, Antonio Chair 1) Merck Sharp & Dohme 1) Advisory Board Carbone, David Chair 1) MSD, EMD Serono, AZ, GSK, DSI 1) Advisory Board 2) Pfizer, AZ, GenePlus, BMS, Inivata, GSK 2) Speakers Bureau Carbone, Michele Faculty Nothing to disclose Nothing to disclose Casali, Paolo Faculty Nothing to disclose Nothing to disclose Cedzynska, Magdalena Faculty Nothing to disclose Nothing to disclose Chai, Hui Zhong Faculty Nothing to disclose Nothing to disclose Chan, Alexandre Faculty Nothing to disclose Nothing to disclose Chan, Joyce Faculty Nothing to disclose Nothing to disclose Chang, Yeun-Chung Faculty Nothing to disclose Nothing to disclose Chaoqiang, Deng Faculty Nothing to disclose Nothing to disclose Charalambous, Andreas Faculty Nothing to disclose Nothing to disclose Chen, Haiquan Faculty Nothing to disclose Nothing to disclose Chen, Jing-Hua Faculty Nothing to disclose Nothing to disclose Chen, Wanqing Faculty Nothing to disclose Nothing to disclose Chen, Xiaoyuan Faculty Nothing to disclose Nothing to disclose Cheung, Yin Bun Faculty Nothing to disclose Nothing to disclose Chiang, Anne Faculty 1) AbbVie, Boehringer Ingelheim, AstraZeneca, Genentech, BMS 1) Advisory Board 2) AstraZeneca 2) Consultant 3) AstraZeneca, BMS, Merck, Amgen , Abbvie 3) Contracted/Support research grant Ching, Shirley Siu-yin Faculty Nothing to disclose Nothing to disclose Chino, Fumiko Faculty 1) Memorial Sloan Kettering Cancer Center 1) Employment 2) NYU Langone Health - Bellevue Hospital 2) Employment -Spouse Cho, Byoung Chul Faculty 1) Novartis, Bayer, AstraZeneca, MOGAM Institute, Dong-A ST, 1) Advisory Board Champions Oncology, Janssen, Yuhan, Ono, Dizal Pharma, MSD, 2) Honorarium received from promotional Abbvie, Medpacto, GIInnovation, Eli Lilly, Blueprint medicines, activities Interpark Bio Convergence Corp 3) Contracted/Support research grant 2) DAAN Biotherapeutics 4) Ownership or Stock interest 3) TheraCanVac Inc, Gencurix Inc, Bridgebio therapeutics, 5) Board of Directors KANAPH Therapeutic Inc, Cyrus therapeutics, Interpark Bio Convergence Corp 4) KANAPH Therapeutic Inc, Brigebio therapeutics, Cyrus therapeutics, Guardant Health 5) Gencurix Inc, Interpark Bio Convergence Corp Chou, Teh-Ying Chair 1) Roche 1) Speakers Bureau, Advisory Board, Consultant Chua, Alfredo Faculty Nothing to disclose Nothing to disclose Chua, Kevin Faculty 1) Astrazeneca 1) Advisory Board 2) National Cancer Centre Singapore 2) Employment Ciupek, Andrew Faculty Nothing to disclose Nothing to disclose 3/21 WCLC 2020 Faculty Chairs Disclosure Summary Name of Individual Individual's Name of Commercial Interest(s) Nature of Relationship(s) Coate, Linda FacultyRole(s) in Activity 1) abbvie 1) Contracted/Support research grant 2) pfizer 2) Speakers/Bureau 3) astellas, astrazeneca, roche, MSD 3) Advisory Board Cooke, Saskia Faculty Nothing to disclose